{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:34:54Z","timestamp":1761222894825,"version":"build-2065373602"},"publisher-location":"Berlin, Heidelberg","reference-count":127,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_332","type":"book-chapter","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:02:58Z","timestamp":1761220978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burkitt Lymphoma"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1113-2829","authenticated-orcid":false,"given":"Ann M.","family":"Moormann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-8204","authenticated-orcid":false,"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0001-5152","authenticated-orcid":false,"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"332_CR1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005158","volume":"11","author":"F Abate","year":"2015","unstructured":"Abate F, Ambrosio MR, Mundo L et al (2015) Distinct viral and mutational spectrum of endemic Burkitt lymphoma. PLoS Pathog 11:e1005158","journal-title":"PLoS Pathog"},{"key":"332_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.1965.14.191","volume":"14","author":"DC Abele","year":"1965","unstructured":"Abele DC, Tobie JE, Hill GJ et al (1965) Alterations in serum proteins and 19s antibody production during the course of induced malarial infections in man. Am J Trop Med Hyg 14:191\u2013197","journal-title":"Am J Trop Med Hyg"},{"key":"332_CR3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classification of Haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"332_CR4","doi-asserted-by":"publisher","unstructured":"Ariera B, Guyah B, Rahkola J et al (2025) Sustained activation induced cytidine deaminase (AID) expression in B cells following plasmodium falciparum malaria infection in Kenyan children. J Immunol. https:\/\/doi.org\/10.1093\/jimmun\/vkaf005","DOI":"10.1093\/jimmun\/vkaf005"},{"key":"332_CR5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","volume":"208","author":"HH Balfour Jr","year":"2013","unstructured":"Balfour HH Jr, Sifakis F, Sliman JA et al (2013) Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis 208:1286\u20131293","journal-title":"J Infect Dis"},{"key":"332_CR6","first-page":"585","volume":"7","author":"S Banerjee","year":"2016","unstructured":"Banerjee S, Uppal T, Strahan R et al (2016) The modulation of apoptotic pathways by gammaherpesviruses. Front Microbiol 7:585","journal-title":"Front Microbiol"},{"key":"332_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40471-021-00271-8","volume":"8","author":"GJ Bell","year":"2021","unstructured":"Bell GJ, Agnandji ST, Asante KP et al (2021) Impacts of ecology, parasite antigenic variation, and human genetics on RTS,S\/AS01e malaria vaccine efficacy. Curr Epidemiol Rep 8:79\u201388","journal-title":"Curr Epidemiol Rep"},{"key":"332_CR8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12879-023-08699-7","volume":"23","author":"GJ Bell","year":"2023","unstructured":"Bell GJ, Gyaase S, Goel V et al (2023) Background malaria incidence and parasitemia during the three-dose RTS,S\/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria. BMC Infect Dis 23:716","journal-title":"BMC Infect Dis"},{"key":"332_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ijc.2910220304","volume":"22","author":"RJ Biggar","year":"1978","unstructured":"Biggar RJ, Henle W, Fleisher G et al (1978) Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 22:239\u2013243","journal-title":"Int J Cancer"},{"key":"332_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.it.2010.08.003","volume":"31","author":"NK Bj\u00f6rkstr\u00f6m","year":"2010","unstructured":"Bj\u00f6rkstr\u00f6m NK, Ljunggren H-G, Sandberg JK (2010) CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol 31:401\u2013406","journal-title":"Trends Immunol"},{"key":"332_CR11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41577-024-01041-5","volume":"24","author":"MJ Boyle","year":"2024","unstructured":"Boyle MJ, Engwerda CR, Jagannathan P (2024) The impact of plasmodium-driven immunoregulatory networks on immunity to malaria. Nat Rev Immunol 24:637\u2013653","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 2","key":"332_CR12","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1093\/infdis\/jit319","volume":"208","author":"MA Brehm","year":"2013","unstructured":"Brehm MA, Shultz LD, Luban J, Greiner DL (2013) Overcoming current limitations in humanized mouse research. J Infect Dis 208(Suppl 2):S125\u2013S130","journal-title":"J Infect Dis"},{"key":"332_CR13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/ijc.30170","volume":"139","author":"G Buckle","year":"2016","unstructured":"Buckle G, Maranda L, Skiles J et al (2016) Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: a historical cohort study. Int J Cancer 139:1231\u20131240","journal-title":"Int J Cancer"},{"key":"332_CR14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D Burkitt","year":"1958","unstructured":"Burkitt D (1958) A sarcoma involving the jaws in African children. Br J Surg 46:218\u2013223","journal-title":"Br J Surg"},{"key":"332_CR15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.2.5311.1019","volume":"2","author":"D Burkitt","year":"1962","unstructured":"Burkitt D (1962a) Determining the climatic limitations of a children\u2019s cancer common in Africa. Br Med J 2:1019\u20131023","journal-title":"Br Med J"},{"key":"332_CR16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/bjc.1962.43","volume":"16","author":"D Burkitt","year":"1962","unstructured":"Burkitt D (1962b) A \u201ctumour safari\u201d in East and Central Africa. Br J Cancer 16:379\u2013386","journal-title":"Br J Cancer"},{"key":"332_CR17","first-page":"19","volume":"42","author":"DP Burkitt","year":"1969","unstructured":"Burkitt DP (1969) Etiology of Burkitt\u2019s lymphoma \u2013 an alternative hypothesis to a vectored virus. J Natl Cancer Inst 42:19\u201328","journal-title":"J Natl Cancer Inst"},{"key":"332_CR18","first-page":"258","volume":"14","author":"D Burkitt","year":"1961","unstructured":"Burkitt D, O\u2019conor GT (1961) Malignant lymphoma in African children. Lancet 14:258\u2013269","journal-title":"Lancet"},{"key":"332_CR19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011561","volume":"19","author":"AM Burnet","year":"2023","unstructured":"Burnet AM, Brunetti T, Rochford R (2023) Hemin treatment drives viral reactivation and plasma cell differentiation of EBV latently infected B cells. PLoS Pathog 19:e1011561","journal-title":"PLoS Pathog"},{"key":"332_CR20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/ijc.23254","volume":"122","author":"LM Carpenter","year":"2008","unstructured":"Carpenter LM, Newton R, Casabonne D et al (2008) Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer 122:1319\u20131323","journal-title":"Int J Cancer"},{"key":"332_CR21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41577-023-00867-9","volume":"23","author":"K Chamoto","year":"2023","unstructured":"Chamoto K, Yaguchi T, Tajima M, Honjo T (2023) Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1. Nat Rev Immunol 23:682\u2013695","journal-title":"Nat Rev Immunol"},{"key":"332_CR22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3892\/or.2014.3625","volume":"33","author":"M Chao","year":"2015","unstructured":"Chao M, Wang H-N, Lu YJ et al (2015) The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal. Oncol Rep 33:958\u2013966","journal-title":"Oncol Rep"},{"key":"332_CR23","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/JVI.02158-12","volume":"87","author":"PK Chattopadhyay","year":"2013","unstructured":"Chattopadhyay PK, Chelimo K, Embury PB et al (2013) Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation. J Virol 87:1779\u20131788","journal-title":"J Virol"},{"key":"332_CR24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030080","volume":"3","author":"A Ch\u00eane","year":"2007","unstructured":"Ch\u00eane A, Donati D, Guerreiro-Cacais AO et al (2007) A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 3:e80","journal-title":"PLoS Pathog"},{"key":"332_CR25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4161\/cbt.9.12.11995","volume":"9","author":"T Choudhuri","year":"2010","unstructured":"Choudhuri T, Murakami M, Kaul R et al (2010) Nm23-H1 can induce cell cycle arrest and apoptosis in B cells. Cancer Biol Ther 9:1065\u20131078","journal-title":"Cancer Biol Ther"},{"key":"332_CR26","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","volume":"205","author":"EY-W Choy","year":"2008","unstructured":"Choy EY-W, Siu K-L, Kok K-H et al (2008) An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205:2551\u20132560","journal-title":"J Exp Med"},{"key":"332_CR27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin J, Buettner H, Seedhom MO et al (2023) Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol 20:192\u2013206","journal-title":"Nat Rev Clin Oncol"},{"key":"332_CR28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/ciu342","volume":"59","author":"LM Condon","year":"2014","unstructured":"Condon LM, Cederberg LE, Rabinovitch MD et al (2014) Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race\/ethnicity and family environment. Clin Infect Dis 59:501\u2013508","journal-title":"Clin Infect Dis"},{"key":"332_CR29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000004","volume":"4","author":"KN Couper","year":"2008","unstructured":"Couper KN, Blount DG, Wilson MS et al (2008) IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 4:e1000004","journal-title":"PLoS Pathog"},{"key":"332_CR30","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3389\/fimmu.2018.02445","volume":"9","author":"KW Dantzler","year":"2018","unstructured":"Dantzler KW, Jagannathan P (2018) \u0393\u03b4 T cells in antimalarial immunity: new insights into their diverse functions in protection and tolerance. Front Immunol 9:2445","journal-title":"Front Immunol"},{"key":"332_CR31","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3389\/fimmu.2018.02973","volume":"9","author":"K Deroost","year":"2018","unstructured":"Deroost K, Langhorne J (2018) Gamma\/Delta T cells and their role in protection against malaria. Front Immunol 9:2973","journal-title":"Front Immunol"},{"key":"332_CR32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(77)91137-0","volume":"1","author":"G De-The","year":"1977","unstructured":"De-The G (1977) Is Burkitt\u2019s lymphoma related to perinatal infection by Epstein-Barr virus? Lancet 1:335\u2013338","journal-title":"Lancet"},{"key":"332_CR33","first-page":"3","volume":"1971","author":"G De-The","year":"1975","unstructured":"De-The G, Day NE, Geser A et al (1975) Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study \u2013 a review. IARC Sci Publ 1971:3\u201316","journal-title":"IARC Sci Publ"},{"key":"332_CR34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/274756a0","volume":"274","author":"G De-The","year":"1978","unstructured":"De-The G, Geser A, Day NE et al (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt\u2019s lymphoma from Ugandan prospective study. Nature 274:756\u2013761","journal-title":"Nature"},{"key":"332_CR35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.20161017","volume":"214","author":"Z Djaoud","year":"2017","unstructured":"Djaoud Z, Guethlein LA, Horowitz A et al (2017) Two alternate strategies for innate immunity to Epstein-Barr virus: one using NK cells and the other NK cells and \u03b3\u03b4 T cells. J Exp Med 214:1827\u20131841","journal-title":"J Exp Med"},{"key":"332_CR36","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1128\/IAI.72.9.5412-5418.2004","volume":"72","author":"D Donati","year":"2004","unstructured":"Donati D, Zhang LP, Ch\u00eane A et al (2004) Identification of a polyclonal B-cell activator in plasmodium falciparum. Infect Immun 72:5412\u20135418","journal-title":"Infect Immun"},{"key":"332_CR37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 1:702\u2013703","journal-title":"Lancet"},{"key":"332_CR38","doi-asserted-by":"publisher","unstructured":"Falanga YT, Frascoli M, Kaymaz Y et al (2017) High pathogen burden in childhood promotes the development of unconventional innate-like CD8+ T cells. JCI Insight 2. https:\/\/doi.org\/10.1172\/jci.insight.93814","DOI":"10.1172\/jci.insight.93814"},{"key":"332_CR39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.it.2020.04.009","volume":"41","author":"Y Feng","year":"2020","unstructured":"Feng Y, Seija N, Di Noia JM, Martin A (2020) AID in antibody diversification: there and back again. Trends Immunol 41:586\u2013600","journal-title":"Trends Immunol"},{"key":"332_CR40","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/bloodadvances.2017015404","volume":"2","author":"CS Forconi","year":"2018","unstructured":"Forconi CS, Cosgrove CP, Saikumar-Lakshmi P et al (2018) Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas. Blood Adv 2:1101\u20131114","journal-title":"Blood Adv"},{"key":"332_CR41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fcimb.2020.00162","volume":"10","author":"CS Forconi","year":"2020","unstructured":"Forconi CS, Oduor CI, Oluoch PO et al (2020) A new hope for CD56negCD16pos NK cells as unconventional cytotoxic mediators: an adaptation to chronic diseases. Front Cell Infect Microbiol 10:162","journal-title":"Front Cell Infect Microbiol"},{"key":"332_CR42","doi-asserted-by":"publisher","unstructured":"Forconi CS, Mulama DH, Saikumar Lakshmi P et al (2021) Interplay between IL-10, IFN-\u03b3, IL-17A and PD-1 expressing EBNA1-specific CD4+ and CD8+ T cell responses in the etiologic pathway to endemic Burkitt lymphoma. Cancer 13. https:\/\/doi.org\/10.3390\/cancers13215375","DOI":"10.3390\/cancers13215375"},{"key":"332_CR43","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/v4091537","volume":"4","author":"L Frappier","year":"2012","unstructured":"Frappier L (2012) Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses 4:1537\u20131547","journal-title":"Viruses"},{"key":"332_CR44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2875-6-69","volume":"6","author":"G Futagbi","year":"2007","unstructured":"Futagbi G, Welbeck JE, Tetteh JKA et al (2007) Selective activation of TCR-gammadelta+ cells in endemic Burkitt\u2019s lymphoma. Malar J 6:69","journal-title":"Malar J"},{"key":"332_CR45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ijc.2910290406","volume":"29","author":"A Geser","year":"1982","unstructured":"Geser A, de Th\u00e9 G, Lenoir G et al (1982) Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt\u2019s lymphoma. Int J Cancer 29:397\u2013400","journal-title":"Int J Cancer"},{"key":"332_CR46","unstructured":"GMP (2024) World malaria report 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240104440. Accessed 14 May 2025"},{"key":"332_CR47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","volume":"133","author":"BM Grande","year":"2019","unstructured":"Grande BM, Gerhard DS, Jiang A et al (2019) Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 133:1313\u20131324","journal-title":"Blood"},{"key":"332_CR48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40656-021-00383-w","volume":"43","author":"S Green","year":"2021","unstructured":"Green S, Dam MS, Svendsen MN (2021) Mouse avatars of human cancers: the temporality of translation in precision oncology. Hist Philos Life Sci 43:27","journal-title":"Hist Philos Life Sci"},{"key":"332_CR49","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4049\/jimmunol.149.12.3984","volume":"149","author":"G H\u00e4cker","year":"1992","unstructured":"H\u00e4cker G, Kromer S, Falk M et al (1992) V delta 1+ subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. J Immunol 149:3984\u20133989","journal-title":"J Immunol"},{"key":"332_CR50","first-page":"429","volume":"40","author":"AJ Haddow","year":"1963","unstructured":"Haddow AJ (1963) An improved map for the study of Burkitt\u2019s lymphoma syndrome in Africa. East Afr Med J 40:429\u2013432","journal-title":"East Afr Med J"},{"key":"332_CR51","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1182\/blood-2006-05-023663","volume":"109","author":"KN Heller","year":"2007","unstructured":"Heller KN, Upshaw J, Seyoum B et al (2007) Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers. Blood 109:1138\u20131146","journal-title":"Blood"},{"key":"332_CR52","doi-asserted-by":"crossref","unstructured":"Henle W, Henle G (1976) The sero-epidemiology of Epstein-Barr virus. Adv Pathobiol:5\u201317","DOI":"10.1002\/ijc.2910170102"},{"key":"332_CR53","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1042\/BST0320731","volume":"32","author":"MN Holowaty","year":"2004","unstructured":"Holowaty MN, Frappier L (2004) HAUSP\/USP7 as an Epstein-Barr virus target. Biochem Soc Trans 32:731\u2013732","journal-title":"Biochem Soc Trans"},{"key":"332_CR54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-981-15-3532-1_4","volume":"1254","author":"C Huang","year":"2020","unstructured":"Huang C (2020) Germinal Center reaction. Adv Exp Med Biol 1254:47\u201353","journal-title":"Adv Exp Med Biol"},{"key":"332_CR55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0065-230X(10)07004-1","volume":"107","author":"D Iwakiri","year":"2010","unstructured":"Iwakiri D, Takada K (2010) Role of EBERs in the pathogenesis of EBV infection. Adv Cancer Res 107:119\u2013136","journal-title":"Adv Cancer Res"},{"key":"332_CR56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1073\/pnas.0908946107","volume":"107","author":"M Jankovic","year":"2010","unstructured":"Jankovic M, Robbiani DF, Dorsett Y et al (2010) Role of the translocation partner in protection against AID-dependent chromosomal translocations. Proc Natl Acad Sci USA 107:187\u2013192","journal-title":"Proc Natl Acad Sci USA"},{"key":"332_CR57","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.18632\/oncotarget.14045","volume":"8","author":"A Jud","year":"2017","unstructured":"Jud A, Kotur M, Berger C et al (2017) Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-\u03b3. Oncotarget 8:6130\u20136141","journal-title":"Oncotarget"},{"key":"332_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910060102","volume":"6","author":"GW Kafuko","year":"1970","unstructured":"Kafuko GW, Burkitt DP (1970) Burkitt\u2019s lymphoma and malaria. Int J Cancer 6:1\u20139","journal-title":"Int J Cancer"},{"key":"332_CR59","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.20160120","volume":"213","author":"JS Kalchschmidt","year":"2016","unstructured":"Kalchschmidt JS, Bashford-Rogers R, Paschos K et al (2016) Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells. J Exp Med 213:921\u2013928","journal-title":"J Exp Med"},{"key":"332_CR60","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1128\/JVI.02596-07","volume":"82","author":"M-S Kang","year":"2008","unstructured":"Kang M-S, Soni V, Bronson R, Kieff E (2008) Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL\/6J mice. J Virol 82:4180\u20134183","journal-title":"J Virol"},{"key":"332_CR61","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","volume":"15","author":"Y Kaymaz","year":"2017","unstructured":"Kaymaz Y, Oduor CI, Yu H et al (2017) Comprehensive transcriptome and mutational profiling of endemic Burkitt lymphoma reveals EBV type-specific differences. Mol Cancer Res 15:563\u2013576","journal-title":"Mol Cancer Res"},{"key":"332_CR62","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","volume":"79","author":"GL Kelly","year":"2005","unstructured":"Kelly GL, Milner AE, Tierney RJ et al (2005) Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt\u2019s lymphoma cells and with increased resistance to apoptosis. J Virol 79:10709\u201310717","journal-title":"J Virol"},{"key":"332_CR63","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","volume":"100","author":"G Kennedy","year":"2003","unstructured":"Kennedy G, Komano J, Sugden B (2003) Epstein-Barr virus provides a survival factor to Burkitt\u2019s lymphomas. Proc Natl Acad Sci USA 100:14269\u201314274","journal-title":"Proc Natl Acad Sci USA"},{"key":"332_CR64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.micro.54.1.19","volume":"54","author":"R Khanna","year":"2000","unstructured":"Khanna R, Burrows SR (2000) Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. Ann Rev Microbiol 54:19\u201348","journal-title":"Ann Rev Microbiol"},{"key":"332_CR65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.19-0830","volume":"103","author":"CH King","year":"2020","unstructured":"King CH, Binder S, Shen Y et al (2020) SCORE studies on the impact of drug treatment on morbidity due to Schistosoma mansoni and Schistosoma haematobium infection. Am J Trop Med Hyg 103:30\u201335","journal-title":"Am J Trop Med Hyg"},{"key":"332_CR66","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1093\/emboj\/19.24.6742","volume":"19","author":"N Kitagawa","year":"2000","unstructured":"Kitagawa N, Goto M, Kurozumi K et al (2000) Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt\u2019s lymphoma growth through interleukin-10 induction. EMBO J 19:6742\u20136750","journal-title":"EMBO J"},{"key":"332_CR67","doi-asserted-by":"crossref","unstructured":"Klein G (1979) The role of viral transformation and cytogenetic changes in viral oncogenesis. Ciba Found Symp 335\u2013358","DOI":"10.1002\/9780470720486.ch14"},{"key":"332_CR68","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","volume":"73","author":"J Komano","year":"1999","unstructured":"Komano J, Maruo S, Kurozumi K et al (1999) Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt\u2019s lymphoma cell line Akata. J Virol 73:9827\u20139831","journal-title":"J Virol"},{"key":"332_CR69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2019.00229","volume":"10","author":"R Kumar","year":"2019","unstructured":"Kumar R, Ng S, Engwerda C (2019) The role of IL-10 in malaria: a double edged sword. Front Immunol 10:229","journal-title":"Front Immunol"},{"key":"332_CR70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1097-0215(19990331)81:1<6::AID-IJC2>3.0.CO;2-2","volume":"81","author":"LG Labrecque","year":"1999","unstructured":"Labrecque LG, Xue SA, Kazembe P et al (1999) Expression of Epstein-Barr virus lytically related genes in African Burkitt\u2019s lymphoma: correlation with patient response to therapy. Int J Cancer 81:6\u201311","journal-title":"Int J Cancer"},{"key":"332_CR71","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","volume":"79","author":"LL Laichalk","year":"2005","unstructured":"Laichalk LL, Thorley-Lawson DA (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79:1296\u20131307","journal-title":"J Virol"},{"key":"332_CR72","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0140-6736(91)90203-2","volume":"337","author":"KM Lam","year":"1991","unstructured":"Lam KM, Syed N, Whittle H, Crawford DH (1991) Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 337:876\u2013878","journal-title":"Lancet"},{"key":"332_CR73","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3389\/fimmu.2019.02193","volume":"10","author":"HM Long","year":"2019","unstructured":"Long HM, Meckiff BJ, Taylor GS (2019) The T-cell response to Epstein-Barr virus-new tricks from an old dog. Front Immunol 10:2193","journal-title":"Front Immunol"},{"key":"332_CR74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","volume":"8","author":"C L\u00f3pez","year":"2022","unstructured":"L\u00f3pez C, Burkhardt B, Chan JKC et al (2022) Burkitt lymphoma. Nat Rev Dis Primers 8:78","journal-title":"Nat Rev Dis Primers"},{"key":"332_CR75","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2010.10.029","volume":"410","author":"J Lu","year":"2011","unstructured":"Lu J, Murakami M, Verma SC et al (2011) Epstein-Barr virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 410:64\u201375","journal-title":"Virology"},{"key":"332_CR76","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/excr.1995.1083","volume":"217","author":"MC Marin","year":"1995","unstructured":"Marin MC, Hsu B, Stephens LC et al (1995) The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res 217:240\u2013247","journal-title":"Exp Cell Res"},{"key":"332_CR77","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.virol.2011.01.028","volume":"412","author":"AR Marquitz","year":"2011","unstructured":"Marquitz AR, Mathur A, Nam CS, Raab-Traub N (2011) The Epstein-Barr virus BART microRNAs target the pro-apoptotic protein Bim. Virology 412:392\u2013400","journal-title":"Virology"},{"key":"332_CR78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2023","unstructured":"Mills KHG (2023) IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol 23:38\u201354","journal-title":"Nat Rev Immunol"},{"key":"332_CR79","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/428910","volume":"191","author":"AM Moormann","year":"2005","unstructured":"Moormann AM, Chelimo K, Sumba OP et al (2005) Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 191:1233\u20131238","journal-title":"J Infect Dis"},{"key":"332_CR80","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/511984","volume":"195","author":"AM Moormann","year":"2007","unstructured":"Moormann AM, Chelimo K, Sumba PO et al (2007) Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 195:799\u2013808","journal-title":"J Infect Dis"},{"key":"332_CR81","first-page":"1721","volume":"124","author":"AM Moormann","year":"2009","unstructured":"Moormann AM, Heller KN, Chelimo K (2009) Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-\u03b3 T cell responses. J Cancer 124:1721\u20131726","journal-title":"J Cancer"},{"key":"332_CR82","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12628","volume":"41","author":"AM Moormann","year":"2019","unstructured":"Moormann AM, Nixon CE, Forconi CS (2019) Immune effector mechanisms in malaria: an update focusing on human immunity. Parasite Immunol 41:e12628","journal-title":"Parasite Immunol"},{"key":"332_CR83","unstructured":"Morrow RH Jr (1985) Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt\u2019s lymphoma. IARC Sci Publ:177\u2013186"},{"key":"332_CR84","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ijc.2910220604","volume":"22","author":"DJ Moss","year":"1978","unstructured":"Moss DJ, Rickinson AB, Pope JH (1978) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 22:662\u2013668","journal-title":"Int J Cancer"},{"key":"332_CR85","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ijc.2910230506","volume":"23","author":"DJ Moss","year":"1979","unstructured":"Moss DJ, Rickinson AB, Pope JH (1979) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer 23:618\u2013625","journal-title":"Int J Cancer"},{"key":"332_CR86","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ijc.2910310609","volume":"31","author":"DJ Moss","year":"1983","unstructured":"Moss DJ, Burrows SR, Castelino DJ et al (1983) A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea. Int J Cancer 31:727\u2013732","journal-title":"Int J Cancer"},{"key":"332_CR87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coviro.2017.07.026","volume":"25","author":"C M\u00fcnz","year":"2017","unstructured":"M\u00fcnz C (2017) Humanized mouse models for Epstein Barr virus infection. Curr Opin Virol 25:113\u2013118","journal-title":"Curr Opin Virol"},{"key":"332_CR88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002505","volume":"3","author":"N Mutalima","year":"2008","unstructured":"Mutalima N, Molyneux E, Jaffe H et al (2008) Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One 3:e2505","journal-title":"PLoS One"},{"key":"332_CR89","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V77.5.1092.1092","volume":"77","author":"A Neri","year":"1991","unstructured":"Neri A, Barriga F, Inghirami G et al (1991) Epstein-Barr virus infection precedes clonal expansion in Burkitt\u2019s and acquired immunodeficiency syndrome-associated lymphoma. Blood 77:1092\u20131095","journal-title":"Blood"},{"key":"332_CR90","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood.V86.2.659.bloodjournal862659","volume":"86","author":"G Niedobitek","year":"1995","unstructured":"Niedobitek G, Agathanggelou A, Rowe M et al (1995) Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt\u2019s lymphoma. Blood 86:659\u2013665","journal-title":"Blood"},{"key":"332_CR91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/594373","volume":"199","author":"R Njie","year":"2009","unstructured":"Njie R, Bell AI, Jia H et al (2009) The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J Infect Dis 199:31\u201338","journal-title":"J Infect Dis"},{"key":"332_CR92","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM198202183060711","volume":"306","author":"RS Nussenzweig","year":"1982","unstructured":"Nussenzweig RS (1982) Parasitic disease as a cause of immunosuppression. N Engl J Med 306:423\u2013424","journal-title":"N Engl J Med"},{"key":"332_CR93","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/jnci\/58.5.1191","volume":"58","author":"CL Olweny","year":"1977","unstructured":"Olweny CL, Atine I, Kaddu-Mukasa A et al (1977) Epstein-Barr virus genome studies in Burkitt\u2019s and non-Burkitt\u2019s lymphomas in Uganda. J Natl Cancer Inst 58:1191\u20131196","journal-title":"J Natl Cancer Inst"},{"key":"332_CR94","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/eji.1830241243","volume":"24","author":"DL Orsini","year":"1994","unstructured":"Orsini DL, van Gils M, Kooy YM et al (1994) Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells. Eur J Immunol 24:3199\u20133204","journal-title":"Eur J Immunol"},{"key":"332_CR95","doi-asserted-by":"publisher","unstructured":"Panea RI, Love CL, Shingleton JR et al (2019) The whole genome landscape of Burkitt lymphoma subtypes. Blood. https:\/\/doi.org\/10.1182\/blood.2019001880","DOI":"10.1182\/blood.2019001880"},{"key":"332_CR96","volume":"11","author":"E Parsons","year":"2016","unstructured":"Parsons E, Otieno JA et al (2016) Regulatory T cells in endemic Burkitt lymphoma patients are associated with poor outcomes: a prospective, longitudinal study. PLoS One 11:e0167841","journal-title":"PLoS One"},{"key":"332_CR97","first-page":"1088","volume":"81","author":"E Piriou","year":"2009","unstructured":"Piriou E, Kimmel R, Chelimo K (2009) Serological evidence for long-term epstein\u2013barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med 81:1088","journal-title":"J Med"},{"key":"332_CR98","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/infdis\/jir872","volume":"205","author":"E Piriou","year":"2012","unstructured":"Piriou E, Asito AS, Sumba PO et al (2012) Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis 205:906\u2013913","journal-title":"J Infect Dis"},{"key":"332_CR99","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-3156.2007.01875.x","volume":"12","author":"JJ Rainey","year":"2007","unstructured":"Rainey JJ, Mwanda WO, Wairiumu P et al (2007) Spatial distribution of Burkitt\u2019s lymphoma in Kenya and association with malaria risk. Trop Med Int Health 12:936\u2013943","journal-title":"Trop Med Int Health"},{"key":"332_CR100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-3083.2005.01589.x","volume":"61","author":"N Rasti","year":"2005","unstructured":"Rasti N, Falk KI, Donati D et al (2005) Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol 61:461\u2013465","journal-title":"Scand J Immunol"},{"key":"332_CR101","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/jiv525","volume":"213","author":"A Reynaldi","year":"2016","unstructured":"Reynaldi A, Schlub TE, Chelimo K et al (2016) Impact of plasmodium falciparum coinfection on longitudinal Epstein-Barr virus kinetics in Kenyan children. J Infect Dis 213:985\u2013991","journal-title":"J Infect Dis"},{"key":"332_CR102","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","volume":"15","author":"AB Rickinson","year":"1997","unstructured":"Rickinson AB, Moss DJ (1997) Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15:405\u2013431","journal-title":"Annu Rev Immunol"},{"key":"332_CR103","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ijc.2910230505","volume":"23","author":"AB Rickinson","year":"1979","unstructured":"Rickinson AB, Moss DJ, Pope JH (1979) Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int J Cancer 23:610\u2013617","journal-title":"Int J Cancer"},{"key":"332_CR1000","doi-asserted-by":"crossref","unstructured":"Rickinson AB, Moss DJ, Allen DJ, et al (1981) Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Int J Cancer 27:593\u2013601","DOI":"10.1002\/ijc.2910270505"},{"key":"332_CR104","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2015.07.019","volume":"162","author":"DF Robbiani","year":"2015","unstructured":"Robbiani DF, Deroubaix S, Feldhahn N et al (2015) Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma. Cell 162:727\u2013737","journal-title":"Cell"},{"key":"332_CR105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/aol-21-18","volume":"5","author":"R Rochford","year":"2021","unstructured":"Rochford R (2021) Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants. Ann Lymphoma 5:22\u201322","journal-title":"Ann Lymphoma"},{"key":"332_CR106","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","volume":"24","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal PJ, Asua V, Bailey JA et al (2024) The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect Dis 24:e591\u2013e600","journal-title":"Lancet Infect Dis"},{"key":"332_CR107","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","volume":"6","author":"M Rowe","year":"1987","unstructured":"Rowe M, Rowe DT, Gregory CD et al (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt\u2019s lymphoma cells. EMBO J 6:2743\u20132751","journal-title":"EMBO J"},{"key":"332_CR108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0020-7519(96)00149-X","volume":"27","author":"CM Rzepczyk","year":"1997","unstructured":"Rzepczyk CM, Anderson K, Stamatiou S et al (1997) Gamma delta T cells: their immunobiology and role in malaria infections. Int J Parasitol 27:191\u2013200","journal-title":"Int J Parasitol"},{"key":"332_CR109","doi-asserted-by":"publisher","unstructured":"Saikumar Lakshmi P, Oduor CI, Forconi CS et al (2023) Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies. Life Sci Alliance 6. https:\/\/doi.org\/10.26508\/lsa.202101355","DOI":"10.26508\/lsa.202101355"},{"key":"332_CR110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/infdis\/jiad264","volume":"229","author":"G Samayoa-Reyes","year":"2024","unstructured":"Samayoa-Reyes G, Weigel C, Koech E et al (2024) Effect of malaria infection on Epstein-Barr virus persistence in Kenyan children. J Infect Dis 229:73\u201382","journal-title":"J Infect Dis"},{"key":"332_CR111","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8:247\u2013258","journal-title":"Nat Rev Immunol"},{"key":"332_CR112","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/jvi.68.9.6069-6073.1994","volume":"68","author":"N Shimizu","year":"1994","unstructured":"Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K (1994) Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt\u2019s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 68:6069\u20136073","journal-title":"J Virol"},{"key":"332_CR113","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1128\/IAI.71.12.6766-6774.2003","volume":"71","author":"S Singh","year":"2003","unstructured":"Singh S, Kennedy MC, Long CA et al (2003) Biochemical and immunological characterization of bacterially expressed and refolded plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1. Infect Immun 71:6766\u20136774","journal-title":"Infect Immun"},{"key":"332_CR114","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/87d81085-b796-4295-9468-030300d78cd6","volume":"7","author":"CJ Snider","year":"2012","unstructured":"Snider CJ, Cole SR, Chelimo K et al (2012) Recurrent plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens. PLoS One 7:e31753","journal-title":"PLoS One"},{"key":"332_CR115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004170","volume":"10","author":"C Torgbor","year":"2014","unstructured":"Torgbor C, Awuah P, Deitsch K et al (2014) A multifactorial role for P. Falciparum malaria in endemic Burkitt\u2019s lymphoma pathogenesis. PLoS Pathog 10:e1004170","journal-title":"PLoS Pathog"},{"key":"332_CR116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009217","volume":"17","author":"N Ungerleider","year":"2021","unstructured":"Ungerleider N, Bullard W, Kara M et al (2021) EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape. PLoS Pathog 17:e1009217","journal-title":"PLoS Pathog"},{"key":"332_CR117","doi-asserted-by":"crossref","unstructured":"Westhoff Smith D, Chakravorty A, Hayes M et al (2021) The Epstein-Barr virus oncogene EBNA1 suppresses natural killer cell responses and apoptosis early after infection of peripheral B cells. MBio:e0224321","DOI":"10.1128\/mBio.02243-21"},{"key":"332_CR118","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/312449a0","volume":"312","author":"HC Whittle","year":"1984","unstructured":"Whittle HC, Brown J, Marsh K et al (1984) T-cell control of Epstein-Barr virus-infected B cells is lost during P. Falciparum malaria. Nature 312:449\u2013450","journal-title":"Nature"},{"key":"332_CR119","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02204-23","volume":"14","author":"KA Willard","year":"2023","unstructured":"Willard KA, Barry AP, Oduor CI et al (2023) Viral and host factors drive a type 1 Epstein-Barr virus spontaneous lytic phenotype. MBio 14:e0220423","journal-title":"MBio"},{"key":"332_CR120","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/ijc.29127","volume":"136","author":"JR Wilmore","year":"2015","unstructured":"Wilmore JR, Asito AS, Wei C et al (2015) AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus. Int J Cancer 136:1371\u20131380","journal-title":"Int J Cancer"},{"key":"332_CR121","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/iid3.134","volume":"4","author":"JR Wilmore","year":"2016","unstructured":"Wilmore JR, Maue AC, Rochford R (2016) Infection induces AID expression in transitional and marginal zone B cells. Immun Inflamm Dis 4:497\u2013505","journal-title":"Immun Inflamm Dis"},{"key":"332_CR122","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","volume":"15","author":"JB Wilson","year":"1996","unstructured":"Wilson JB, Bell JL, Levine AJ (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 15:3117\u20133126","journal-title":"EMBO J"},{"key":"332_CR123","first-page":"212","volume":"8","author":"A-S Wolf","year":"2017","unstructured":"Wolf A-S, Sherratt S, Riley EM (2017) NK cells: uncertain allies against malaria. Front Immunol 8:212","journal-title":"Front Immunol"},{"key":"332_CR124","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.10372","volume":"99","author":"S-A Xue","year":"2002","unstructured":"Xue S-A, Labrecque LG, Lu Q-L et al (2002) Promiscuous expression of Epstein-Barr virus genes in Burkitt\u2019s lymphoma from the central African country Malawi. Int J Cancer 99:635\u2013643","journal-title":"Int J Cancer"},{"key":"332_CR125","first-page":"631","volume":"6","author":"H Zan","year":"2015","unstructured":"Zan H, Casali P (2015) Epigenetics of peripheral B-cell differentiation and the antibody response. Front Immunol 6:631","journal-title":"Front Immunol"},{"key":"332_CR126","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","volume":"228","author":"H zur Hausen","year":"1970","unstructured":"zur Hausen H, Schulte-Holthausen H, Klein G et al (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056\u20131058","journal-title":"Nature"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:03:14Z","timestamp":1761220994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":127,"URL":"https:\/\/doi.org\/10.1007\/82_2025_332","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"24 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}